In this podcast, we will explore emerging agents and research into the use of GLP-1 receptor agonists in the management of type 2 diabetes.

Update on GLP-1 Receptor Agonists in Type 2 Diabetes

GetBriefed Podcast is the latest mdBriefCase Group offering, developed to inform healthcare practitioners regarding a variety of relevant medical topics, and available on a convenient downloadable platform. Now, access education from leading medical experts on-the-go!

mdBriefCase Group is Canada’s foremost, online continuing medical education (CME) provider, with a membership of over 110,000 Canadian healthcare practitioners who currently use and help shape content. We provide FREE multimedia, interactive and accredited learning programs written by leading medical specialists and developed by prestigious educational institutions.

Education

GetBriefed Podcast is the latest mdBriefCase Group offering, developed to inform healthcare practitioners regarding a variety of relevant medical topics, and available on a convenient downloadable platform. Now, access education from leading medical experts on-the-go! mdBriefCase Group is Canada’s foremost, online continuing medical education (CME) provider, with a membership of over 110,000 Canadian healthcare practitioners who currently use and help shape content. We provide FREE multimedia, interactive and accredited learning programs written by leading medical specialists and developed by prestigious educational institutions.

Share Update on GLP-1 Receptor Agonists in Type 2 Diabetes

Sign up to save your podcasts

Update on GLP-1 Receptor Agonists in Type 2 Diabetes

Update on GLP-1 Receptor Agonists in Type 2 Diabetes